Drastic decrease in dopamine receptor levels in the striatum of acetylcholinesterase knock-out mouse

Chemico-Biological Interactions

Volumn 183, Issue 1, 2010, Pages 194-201

  Hrabovska, Anna ^a   Farar, Vladimir ^a,d   Bernard, Veronique ^b   Duysen, Ellen G ^c   Brabec, Jiri ^d   Lockridge, Oksana ^c   Myslivecek, Jaromir ^d  

^a Physics and Informatics   (Slovakia)

^b INSERM   (France)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

AChE mouse; Adaptation changes; Cholinergic system; Dopaminergic system; Striatum

Indexed keywords

ACETYLCHOLINESTERASE; CYCLIC AMP; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C;

ADAPTATION; ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL LEVEL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; KNOCKOUT MOUSE; MOUSE; NERVE CELL NETWORK; NONHUMAN;

ACETYLCHOLINESTERASE; ANIMALS; CORPUS STRIATUM; CYCLIC AMP; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; RECEPTORS, ADRENERGIC; RECEPTORS, CHOLINERGIC; RECEPTORS, DOPAMINE; TYPE C PHOSPHOLIPASES;

ANIMALIA;

EID: 71349084564     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.09.025     Document Type: Article

References (49)

1. Xie W., Stribley J.A., Chatonnet A., Wilder P.J., Rizzino A., McComb R.D., Taylor P., Hinrichs S.H., and Lockridge O. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293 (2000) 896-902
2. Duysen G., Stribley J.A., Fry D.L., Hinrichs S.H., and Lockridge O. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Brain Res. Dev. Brain Res. 137 (2002) 43-54
3. Duysen E.G., and Lockridge O. Phenotype comparison of three acetylcholinesterase knockout strains. J. Mol. Neurosci. 30 (2006) 91-92
4. Hrabovska A., Duysen E.G., Sanders J.D., Murrin L.C., and Lockridge O. Delivery of human acetylcholinesterase by adeno-associated virus to the acetylcholinesterase knockout mouse. Chem. Biol. Interact. 157-158 (2005) 71-78
5. Volpicelli-Daley L.A., Hrabovska A., Duysen E.G., Ferguson S.M., Blakely R.D., Lockridge O., and Levey A.I. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol. Pharmacol. 64 (2003) 1309-1316
6. Hartmann J., Kiewert C., Duysen E.G., Lockridge O., Greig N.H., and Klein J. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity. J. Neurochem. 100 (2007) 1421-1429
7. Hartmann J., Kiewert C., Duysen E.G., Lockridge O., and Klein J. Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice. Neurochem. Int. 52 (2008) 972-978
8. Bernard V., Brana C., Liste I., Lockridge O., and Bloch B. Dramatic depletion of cell surface m2 muscarinic receptor due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase-deficient mice. Mol. Cell. Neurosci. 23 (2003) 121-133
9. Myslivecek J., Duysen E.G., and Lockridge O. Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout mice. Naunyn Schmiedebergs Arch. Pharmacol. 376 (2007) 83-92
10. 2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J. Neurosci. 20 (2000) RC69
11. Zhou F.M., Liang Y., and Dani J.A. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4 (2001) 1224-1229
12. Exley R., and Cragg S.J. Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br. J. Pharmacol. 153 Suppl. 1 (2008) S283-297
13. H3yttel J. SCH 23390-the first selective dopamine D-1 antagonist. Eur. J. Pharmacol. 91 (1983) 153-154
14. Billard W., Ruperto V., Crosby G., Iorio L.C., and Barnett A. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci. 35 (1984) 1885-1893
15. Bernard V., Levey A.I., and Bloch B. Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation. J. Neurosci. 19 (1999) 10237-10249
16. Gras C., Amilhon B., Lepicard E.M., Poirel O., Vinatier J., Herbin M., Dumas S., Tzavara E.T., Wade M.R., Nomikos G.G., Hanoun N., Saurini F., Kemel M.L., Gasnier B., Giros B., and El Mestikawy S. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat. Neurosci. 11 (2008) 292-300
17. Dwivedi Y., and Pandey G.N. Repeated administration of dexamethasone increases phosphoinositide-specific phospholipase C activity and mRNA and protein expression of the phospholipase C beta 1 isozyme in rat brain. J. Neurochem. 73 (1999) 780-790
18. Riljak V., Milotova M., Jandova K., Langmeier M., Maresova D., Pokorny J., and Trojan S. Repeated kainic acid administration and hippocampal neuronal degeneration. Prague Med. Rep. 106 (2005) 75-78
19. Drago J., Gerfen C.R., Lachowicz J.E., Steiner H., Hollon T.R., Love P.E., Ooi G.T., Grinberg A., Lee E.J., Huang S.P., et al. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12564-12568
20. Nikulina E.M., Skrinskaya J.A., Avgustinovich D.F., and Popova N.K. Dopaminergic brain system in the quaking mutant mouse. Pharmacol. Biochem. Behav. 50 (1995) 333-337
21. 2 receptors employing spiperone as a native marker. Chembiochem 6 (2005) 1769-1775
22. 2 receptors. Neuropsychopharmacology 30 (2005) 339-349
23. Calabresi P., Picconi B., Parnetti L., and Di Filippo M. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol. 5 (2006) 974-983
24. 5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J. Neurosci. 22 (2002) RC190
25. Putney Jr. J.W. TRP, inositol 1,4,5-trisphosphate receptors, and capacitative calcium entry. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 14669-14671
26. Lefkowitz R.J. Seven transmembrane receptors: something old, something new. Acta Physiol. (Oxford, England) 190 (2007) 9-19
27. Schapira A.H., Bezard E., Brotchie J., Calon F., Collingridge G.L., Ferger B., Hengerer B., Hirsch E., Jenner P., Le Novere N., Obeso J.A., Schwarzschild M.A., Spampinato U., and Davidai G. Novel pharmacological targets for the treatment of Parkinson's disease. Nat. Rev. Drug Discov. 5 (2006) 845-854
28. Gisabella B., Bolshakov V.Y., and Benes F.M. Regulation of synaptic plasticity in a schizophrenia model. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13301-13306
29. Beneyto M., Kristiansen L.V., Oni-Orisan A., McCullumsmith R.E., and Meador-Woodruff J.H. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32 (2007) 1888-1902
30. 2-like receptors inschizophrenia and bipolar illness. J. Cereb. Blood Flow Metab. 17 (1997) 331-342
31. McDonough Jr. J.H., and Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21 (1997) 559-579
32. Wieseler S., Schopfer L., and Lockridge O. Markers of organophosphate exposure in human serum. J. Mol. Neurosci. 30 (2006) 93-94
33. Ding S.J., Carr J., Carlson J.E., Tong L., Xue W., Li Y., Schopfer L.M., Li B., Nachon F., Asojo O., Thompson C.M., Hinrichs S.H., Masson P., and Lockridge O. Five tyrosines and two serines in human albumin are labeled by the organophosphorus agent FP-biotin. Chem. Res. Toxicol. 21 (2008) 1787-1794
34. Erb C., Troost J., Kopf S., Schmitt U., Loffelholz K., Soreq H., and Klein J. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77 (2001) 638-646
35. Adler M., Manley H.A., Purcell A.L., Deshpande S.S., Hamilton T.A., Kan R.K., Oyler G., Lockridge O., Duysen E.G.E.G., and Sheridan R.E. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Muscle Nerve 30 (2004) 317-327
36. Mesulam M.M., Guillozet A., Shaw P., Levey A., Duysen E.G., and Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110 (2002) 627-639
37. Ben-Shaul Y., Benmoyal-Segal L., Ben-Ari S., Bergman H., and Soreq H. Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Eur. J. Neurosci. 23 (2006) 2915-2922
38. 5 receptor-deficient mice. Neuropsychopharmacology 29 (2004) 1620-1627
39. Hur E.M., and Kim K.T. G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. Cell Signal. 14 (2002) 397-405
40. Perrier A.L., Massoulie J., and Krejci E. PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33 (2002) 275-285
41. Dobbertin A., Hrabovska A., Dembele K., Camp S., Taylor P., Krejci E., and Bernard V. Targeting of acetylcholinesterase in neurons in vivo: a dual processing function for the proline-rich membrane anchor subunit and the attachment domain on the catalytic subunit. J. Neurosci. 29 (2009) 4519-4530
42. Feng G., Krejci E., Molgo J., Cunningham J.M., Massoulie J., and Sanes J.R. Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J. Cell Biol. 144 (1999) 1349-1360
43. Paraoanu L.E., and Layer P.G. Mouse AChE binds in vivo to domain IV of laminin-1beta. Chem. Biol. Interact. 157-158 (2005) 411-413
44. Johnson G., Swart C., and Moore S.W. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain. Biochem. J. 411 (2008) 507-514
45. Birikh K.R., Sklan E.H., Shoham S., and Soreq H. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKCbeta II correlates with intensified fear-induced conflict behavior. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 283-288
46. Perry C., Pick M., Podoly E., Gilboa-Geffen A., Zimmerman G., Sklan E.H., Ben-Shaul Y., Diamant S., and Soreq H. Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia. Leukemia 21 (2007) 1472-1480
47. Raheja G., and Gill K.D. Altered cholinergic metabolism and muscarinic receptor linked second messenger pathways after chronic exposure to dichlorvos in rat brain. Toxicol. Ind. Health 23 (2007) 25-37
48. 1 receptor complex in rats self-administering cocaine. Eur. J. Pharmacol. 362 (1998) 9-15
49. Li B., Duysen E.G., Volpicelli-Daley L.A., Levey A.I., and Lockridge O. Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice. Pharmacol. Biochem. Behav. 74 (2003) 977-986